Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

iRhythm raises 2025 sales forecast and launches Zio ECG system in Japan as analysts boost ratings and price targets on strong Q1 performance.

Latest Ratings for IRTC

DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022NeedhamUpgradesHoldBuy Jan 2022JP MorganMaintainsOverweight

View More Analyst Ratings for IRTC

View the Latest Analyst Ratings

read more